CRYBG1 and metastatic malignant neoplasm: Taken together, these findings suggest that in primary cancers, AIM1 expression is largely retained but shows dysregulated protein localization, and that in metastatic cancers, this mislocalization is compounded by an increased tendency to lose AIM1 expression and copy number.